Some stem cell therapies would skip usual FDA rules under new guidelines – Philly.com
Philly.comSome stem cell therapies would skip usual FDA rules under new guidelinesPhilly.comBut the new guidance, put out as a draft in 2014, does not address the explosion of stem cell clinics offering treatments that may be ineffective or worse. Some… Continue reading
